David E. Fisher
Harvard University · 790 works · 49,286 citations · h-index 110
Top works
- p53 Status and the Efficacy of Cancer Therapy in Vivo
- Apoptosis in cancer therapy: Crossing the threshold
- Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
- MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes
- BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma
- Selective BRAFV600E Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Function
- microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family.
- Bcl2 Regulation by the Melanocyte Master Regulator Mitf Modulates Lineage Survival and Melanoma Cell Viability
- Melanocyte biology and skin pigmentation
- c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi
- Regulation of Proliferation-Survival Decisions during Tumor Cell Hypoxia
- Idiotype-like molecules on cells of a human T cell leukemia.
- Mechanisms of Hair Graying: Incomplete Melanocyte Stem Cell Maintenance in the Niche
- MITF: master regulator of melanocyte development and melanoma oncogene
- In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
- atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity
- BRAF Mutations Are Sufficient to Promote Nevi Formation and Cooperate with p53 in the Genesis of Melanoma
- Microphthalmia Gene Product as a Signal Transducer in cAMP-Induced Differentiation of Melanocytes
- Major Response to Imatinib Mesylate in KIT-Mutated Melanoma
- TFEB has DNA-binding and oligomerization properties of a unique helix-loop-helix/leucine-zipper family.